TAMIR BIOTECHNOLOGY, INC.

Profile

Company Names

TAMIR BIOTECHNOLOGY, INC.
ALFACELL CORP

Addresses

51 JFK PARKWAY, 1ST FLOOR WEST, STE 108, SHORT HILLS, NJ 07078

12625 HIGH BLUFF DRIVE, SUITE 213, SAN DIEGO, CA 92130

12625 HIGH BLUFF DRIVE, SUITE 113, SAN DIEGO, CA 92130

5825 OBERLIN DRIVE, SAN DIEGO, CA 92121

11 DEER PARK DRIVE, SUITE 204, PRINCETON CORPORATE PLAZA, MONMOUTH JUNCTION, NJ 08853

300 ATRIUM DRIVE, SOMERSET, NJ 08873

Phone Numbers

(800) 419-5061
(732) 823-1003
732-823-1003
732-652-4525

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$8,436,426.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-01-11 
$808,638.00 
$1,500,000.00 
$691,362.00 
Debt 
6
2016-05-12 
$1,722,476.00 
$1,722,476.00 
$0.00 
Equity 
5
2015-09-04 
$800,000.00 
$800,000.00 
$0.00 
Debt 
4
2014-04-25 
$850,312.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2013-10-03 
$5,000.00 
$600,000.00 
$595,000.00 
Equity 
2
2012-12-14 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
1
2009-10-19 
$3,250,000.00 
$3,250,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOANNE 
 
BARSA 
EXECUTIVE OFFICER
TAMIR BIOTECHNOLOGY, INC.
JOHN 
 
BRANCACCIO 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  SAV ACQUISITION CORP   |  SAV HOLDINGS CORP.   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.   |  RASNA THERAPEUTICS INC.   |  TROVAGENE, INC.   |  CARDIFF ONCOLOGY, INC.
JOHN 
P. 
BRANCACCIO 
DIRECTOR
ALFACELL CORP   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  TROVAGENE, INC.   |  HEPION PHARMACEUTICALS, INC.
STEPHEN 
K. 
CARTER 
DIRECTOR
LIXTE BIOTECHNOLOGY HOLDINGS, INC.   |  ALFACELL CORP
DONALD 
R. 
CONKLIN 
DIRECTOR
ALFACELL CORP
LAWRENCE 
A. 
KENYON 
EXECUTIVE OFFICER
TAMIR BIOTECHNOLOGY, INC.   |  OUTLOOK THERAPEUTICS, INC.
FRED 
 
KNOLL 
DIRECTOR
ATHERONOVA INC.   |  TAMIR BIOTECHNOLOGY, INC.
CHARLES 
 
MUNIZ 
EXECUTIVE OFFICER, DIRECTOR
ALFACELL CORP   |  TAMIR BIOTECHNOLOGY, INC.
PATRICK 
 
OSTRONIC 
DIRECTOR
OASIS GROUP HOLDINGS, INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  MARINA TECHNOLOGY HOLDINGS, INC.   |  MARINALIFE, INC.
PATRICK 
 
OSTRONICK 
DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
KUSLIMA 
 
SHOGEN 
DIRECTOR
ALFACELL CORP
DAVID 
 
SIDRANDKY 
DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
DAVID 
 
SIDRANSKY 
DIRECTOR
ALFACELL CORP   |  KV PHARMACEUTICAL CO /DE/   |  ROSETTA GENOMICS LTD.   |  MORRIA BIOPHARMACEUTICALS PLC   |  CHAMPIONS ONCOLOGY, INC.   |  CELSUS THERAPEUTICS PLC.   |  Y LABS, INC.   |  IMMUNE PHARMACEUTICALS INC   |  ORGENESIS INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  GALMED PHARMACEUTICALS LTD.   |  ISRAEL BIOTECH FUND II, L.P.   |  ADVAXIS, INC.   |  AYALA PHARMACEUTICALS, INC.
JAMIE 
 
SULLEY 
EXECUTIVE OFFICER, DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
JAMIE 
 
SULLY 
EXECUTIVE OFFICER, DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
PAUL 
 
WEISS 
DIRECTOR
EUTHYMICS BIOSCIENCE INC   |  PIPELINE FINANCE LLC   |  AKEBIA THERAPEUTICS, INC.   |  GINNIE ACCEPTANCE COMPANY, LLC   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  WEST HILL STRATEGIC BOND FUND, LP   |  EUTHYMICS BIOSCIENCE, INC.   |  FLUGEN INC   |  INVENRA INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  TEN BAY BIO, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
PAUL 
M. 
WEISS 
DIRECTOR
MITHRIDION INC   |  ALFACELL CORP   |  TAMIR BIOTECHNOLOGY, INC.   |  AERPIO PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-01-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2018-01-11 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-12 
2016-05-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-12 
2015-09-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2015-09-04 
2014-05-19
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-04-25 
2014-05-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-04-25 
2013-10-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-10-03 
2012-12-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
2009-11-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2009-10-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE